False, in her disclosures in the most recent presentation she disclosed her relationship with NWBO not to mention half of her SPORE trials use Murcidencel!
In response to your post, I would like to share my own opinions about the relationships that are so crucial to the development of this new cell-based technology:
UCLA Northwest Biotherapeutics NIH
All three are separate institutions, but all played a crucial role in the development of murcidencel and its successful completion of all three phases of clinical investigation.
Now, Liau and NWBO are aiming toward approval. This is where the NIH again becomes crucial as they work closely with the FDA to ensure the development of safe and efficacious therapies that FDA wants to approve.